Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection. (Q53364717)

13 May 2018

title

Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection. (English)

1 reference

13 May 2018

0 references

van der Meer JT

1

1 reference

13 May 2018

Drew WL

2

1 reference

13 May 2018

Bowden RA

3

1 reference

13 May 2018

Galasso GJ

4

1 reference

13 May 2018

Griffiths PD

5

1 reference

13 May 2018

Jabs DA

6

1 reference

13 May 2018

Katlama C

7

1 reference

13 May 2018

Spector SA

8

1 reference

13 May 2018

Whitley RJ

9

1 reference

13 May 2018

publication date

1 November 1996

1 reference

13 May 2018

published in

Antiviral Research

1 reference

13 May 2018

volume

32

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

119-140

1 reference

13 May 2018

Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recov

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Transfusion-transmitted cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus (CMV)-Specific Intravenous Immunoglobulin for the Prevention of Primary CMV Infection and Disease after Marrow Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Natural history of untreated cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

The predictive value of cytomegalovirus retinitis for cytomegalovirus encephalitis in acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Enhancement of Murine Cytomegalovirus Infection during Graft-vs.-Host Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Prevalence of Cytomegalovirus Infection in Homosexual Men

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Local therapy for cytomegalovirus retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Gastrointestinal cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Low frequency maintenance ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus infection in sex partners: evidence for sexual transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Virus infections after transplantation in man. Brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

The Transplanted Kidney as a Source of Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Risk/benefit ratio of perioperative OKT3 in cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Primate cytomegalovirus assembly: evidence that DNA packaging occurs subsequent to B capsid assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Diagnosis and Treatment of Cytomegalovirus Disease in Transplant Patients Based on Gastrointestinal Tract Manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Increase in severity of graft versus host disease by cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

AIDS-associated cytomegalovirus infection mimicking central nervous system tumors: a diagnostic challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Vaccines for varicella-zoster virus and cytomegalovirus: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

CMV retinitis: ganciclovir/monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Efficacy of cytomegalovirus immunoglobulin in marrow transplant recipients with cytomegalovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Antimicrobial strategies in the care of organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Discrete gastrointestinal mass lesions caused by cytomegalovirus in patients with AIDS: report of three cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

PCR detection of cytomegalovirus: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Detection of IgM antibody to cytomegalovirus and rapid diagnosis of this virus infection by the shell vial assay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Human cytomegalovirus structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Identification of Multiple Cytomegalovirus Strains in Homosexual Men with Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Transmission of cytomegalovirus by renal allograft demonstrated by restriction enzyme analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Enhancement of Mouse Cytomegalovirus Infection During Host-Versus-Graft Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Prevention and treatment of cytomegalovirus pneumonia in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

10.1016/S0166-3542(96)01006-6

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

8955508

1 reference

13 May 2018